PHBI — Pharmagreen Biotech Share Price
0.000.00%
Last trade - 00:00- $0.86m
- $1.17m
- $0.00m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 253 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -7216.13% | ||
Financial Summary
| Year End 30th Sep | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | 0 | 0 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Pharmagreen Biotech, Inc. is a Canada-based company. The Company is engaged in developing its line of nutraceutical products, which is a blend of therapeutic plants and mushrooms. Utilizing the Company's expertise in plant genetics, its transgenic program uses the technology available to research and create nutraceuticals, and daily supplements with the potential to improve lives and address a wide variety of ailing conditions. Its nutraceutical product, MaxGenomic Supplement, comes in a bottle with 60 enteric capsules. The MaxGenomic Supplement is a proprietary blend that consists of nine medicinal mushrooms and six medical plants to help support the human mind and body. Its other nutraceutical products are in various development stages. Its subsidiaries include WFS Pharmagreen Inc, and 1155097 BC Ltd.
Directors
- Last Annual
- September 30th, 2024
- Last Interim
- September 30th, 2024
- Incorporated
- October 16th, 2008
- Public Since
- December 12th, 2008
- No. of Shareholders
- 218
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 663,645,739
- Address
- 2987 Blackbear Crt, COQUITLAM, V3E 3A2
- Web
- https://www.pharmagreen.ca
- Phone
- +1 4046719253
- Contact
- Terry Kwan
- Auditors
- Unaudited
Upcoming Events for PHBI
Q3 2025 Pharmagreen Biotech Inc Earnings Release
Similar to PHBI
Actavia Life Sciences
Pink Sheets on Nasdaq
Acura Pharmaceuticals
Pink Sheets on Nasdaq
Adhera Therapeutics
Pink Sheets on Nasdaq
Ramoil Management
Pink Sheets on Nasdaq
Adynxx
Pink Sheets on Nasdaq
FAQ
What is the Pharmagreen Biotech share price?
As of Today at 22:38 UTC, shares in Pharmagreen Biotech are trading at $0.00. This share price information is delayed by 15 minutes.
How has the Pharmagreen Biotech share price performed this year?
Shares in Pharmagreen Biotech last closed at $0.00 and the price had moved by +85.71% over the past 365 days. In terms of relative price strength the Pharmagreen Biotech share price has outperformed the S&P500 Index by +72.21% over the past year.
What are the analyst and broker recommendations for Pharmagreen Biotech?
There is no consensus recommendation for this security.
Find out moreWhat is the Pharmagreen Biotech dividend yield?
Pharmagreen Biotech does not currently pay a dividend.
Does Pharmagreen Biotech pay a dividend?
Pharmagreen Biotech does not currently pay a dividend.
When does Pharmagreen Biotech next pay dividends?
Pharmagreen Biotech does not currently pay a dividend.
How do I buy Pharmagreen Biotech shares?
To buy shares in Pharmagreen Biotech you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Pharmagreen Biotech?
As of the previous close price of $0.00, shares in Pharmagreen Biotech had a market capitalisation of $0.86m.
Where are Pharmagreen Biotech shares listed?
Here are the trading details for Pharmagreen Biotech:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: PHBI
What kind of share is Pharmagreen Biotech?
Based on an overall assessment of its quality, value and momentum Pharmagreen Biotech is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Pharmagreen Biotech share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Pharmagreen Biotech share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Pharmagreen Biotech. Over the past six months, its share price has underperformed the S&P500 Index by -45.69%.
As of the last closing price of $0.00, shares in Pharmagreen Biotech were trading -27.53% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Pharmagreen Biotech PE Ratio?
The Pharmagreen Biotech PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Pharmagreen Biotech?
Pharmagreen Biotech's management team is headed by:
- Peter Wojcik - PRE
- Terry Kwan - OTH
- Fawzia Afreen - OTH